Your browser doesn't support javascript.
loading
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
Herrick, Ariane L; Pan, Xiaoyan; Peytrignet, Sébastien; Lunt, Mark; Hesselstrand, Roger; Mouthon, Luc; Silman, Alan; Brown, Edith; Czirják, László; Distler, Jörg H W; Distler, Oliver; Fligelstone, Kim; Gregory, William J; Ochiel, Rachel; Vonk, Madelon; Ancuta, Codrina; Ong, Voon H; Farge, Dominique; Hudson, Marie; Matucci-Cerinic, Marco; Balbir-Gurman, Alexandra; Midtvedt, Øyvind; Jordan, Alison C; Jobanputra, Paresh; Stevens, Wendy; Moinzadeh, Pia; Hall, Frances C; Agard, Christian; Anderson, Marina E; Diot, Elisabeth; Madhok, Rajan; Akil, Mohammed; Buch, Maya H; Chung, Lorinda; Damjanov, Nemanja; Gunawardena, Harsha; Lanyon, Peter; Ahmad, Yasmeen; Chakravarty, Kuntal; Jacobsen, Søren; MacGregor, Alexander J; McHugh, Neil; Müller-Ladner, Ulf; Riemekasten, Gabriela; Becker, Michael; Roddy, Janet; Carreira, Patricia E; Fauchais, Anne Laure; Hachulla, Eric; Hamilton, Jennifer.
Affiliation
  • Herrick AL; Centre for Musculoskeletal Research, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Pan X; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Peytrignet S; Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Lunt M; Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Hesselstrand R; Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Mouthon L; Department of Rheumatology, Lund University, Lund, Sweden.
  • Silman A; Service de Médecine Interne, Hôpital Cochin, Centre de Référence pour les Vascularites Nécrosantes et la Sclérodermie Systémique, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Brown E; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,University of Oxford, Oxford, UK.
  • Czirják L; Member of Steering Committee, contact via Professor Herrick, The University of Manchester, Manchester, UK.
  • Distler JHW; Department of Rheumatology and Immunology, Medical Center, University of Pécs, Pecs, Hungary.
  • Distler O; Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Fligelstone K; Department of Rheumatology, University of Zurich, Zurich, Switzerland.
  • Gregory WJ; Royal Free London NHS Foundation Trust, London, UK.
  • Ochiel R; Rehabilitation Services, Salford Royal NHS Foundation Trust, Salford, UK.
  • Vonk M; Royal Free London NHS Foundation Trust, London, UK.
  • Ancuta C; Department of the Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Ong VH; Rheumatology 2 Department, "Grigore T. Popa" University of Medicine and Pharmacy, Clinical Rehabilitation Hospital, Iași, Romania.
  • Farge D; UCL Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, London, UK.
  • Hudson M; Unité Clinique de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire, UF 04, Hôpital Saint-Louis, AP-HP Assistance Publique des Hôpitaux de Paris, INSERM UMRS 1160, Paris Denis Diderot University, France.
  • Matucci-Cerinic M; Jewish General Hospital, Lady Davis Institute and McGill University, Montreal, Canada.
  • Balbir-Gurman A; Department Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy.
  • Midtvedt Ø; Shine Rheumatology Unit, Rambam Heath Care Campus; Rappaport Faculty of Medicine, Haifa, Israel.
  • Jordan AC; Rheumatology Unit, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Jobanputra P; Queen Elizabeth Hospital Birmingham, UHB Foundation Trust, Birmingham, UK.
  • Stevens W; Queen Elizabeth Hospital Birmingham, UHB Foundation Trust, Birmingham, UK.
  • Moinzadeh P; St Vincent's Hospital, Melbourne, Australia.
  • Hall FC; Department for Dermatology, University of Cologne Kerpenerstr. 62, Köln, Germany.
  • Agard C; Cambridge University NHS Hospital Foundation Trust, Cambridge, UK.
  • Anderson ME; Department of Internal Medicine, Hôtel-Dieu Hospital, University of Nantes, Nantes, France.
  • Diot E; University of Liverpool, Aintree University Hospital, Liverpool, UK.
  • Madhok R; Service de Médecine Interne, Hôpital Bretonneau Tours Cedex, France.
  • Akil M; Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK.
  • Buch MH; Sheffield Teaching Hospitals, Sheffield, UK.
  • Chung L; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK.
  • Damjanov N; Stanford University, Stanford, California, USA.
  • Gunawardena H; University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia.
  • Lanyon P; Clinical and Academic Rheumatology, North Bristol NHS Trust, Bristol, UK.
  • Ahmad Y; Nottingham University Hospitals NHS Trust, and Nottingham NHS Treatment Centre, Nottingham, UK.
  • Chakravarty K; Peter Maddison Rheumatology Centre, Llandudno, UK.
  • Jacobsen S; Queens Hospital, Romford, UK.
  • MacGregor AJ; University of Copenhagen, Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.
  • McHugh N; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Müller-Ladner U; Royal National Hospital for Rheumatic Diseases, Bath, UK.
  • Riemekasten G; Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Bad Nauheim, Germany.
  • Becker M; Department of Rheumatology, University of Lübeck, Lübeck, Germany.
  • Roddy J; Department of Rheumatology and Clinical Immunology, University Hospital Charité Berlin, Berlin, Germany.
  • Carreira PE; Department of Rheumatology, Royal Perth Hospital, Perth, Australia.
  • Fauchais AL; Servicio de Reumatologia. Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Hachulla E; Internal Medicine Unit, Limoges University Hospital, France.
  • Hamilton J; Département de Médecine Interne et Immunologie Clinique, Centre National de Référence Maladies Systémiques etAuto-immunes Rares, Université de Lille, Inserm, U995, FHU Immune-Mediated Inflammatory Diseases and Targeted Therapies, Lille, France.
Ann Rheum Dis ; 76(7): 1207-1218, 2017 Jul.
Article in En | MEDLINE | ID: mdl-28188239
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Cyclophosphamide / Scleroderma, Diffuse / Immunosuppressive Agents / Mycophenolic Acid Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Rheum Dis Year: 2017 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Cyclophosphamide / Scleroderma, Diffuse / Immunosuppressive Agents / Mycophenolic Acid Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Rheum Dis Year: 2017 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido